| |
| |
|
| Insider
Information: |
Reardon Tighe |
| Relationship: |
|
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
174,989 |
|
|
Indirect Shares
|
3,340,018 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,515,007 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synthorx, Inc. |
THOR |
Acting Chief Financial... |
2020-01-23 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Janux Therapeutics, Inc. |
JANX |
|
2024-06-03 |
174,989 |
2024-06-03 |
3,340,018 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JANX |
Janux Therapeutics, Inc. |
Acting Chief Financial Officer |
• – – |
2024-06-03 |
4 |
S |
$54.75 |
$45,043,975 |
I/I |
(822,721) |
3,340,018 |
0 |
- |
|
| JANX |
Janux Therapeutics, Inc. |
Acting Chief Financial Officer |
• – • |
2021-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
172,935 |
|
- |
|
| THOR |
Synthorx, Inc. |
Acting Chief Financial Officer |
• – – |
2020-01-23 |
4 |
D |
$68.00 |
$2,970,784 |
D/D |
(43,688) |
0 |
0 |
- |
|
| THOR |
Synthorx, Inc. |
Acting Chief Financial Officer |
• – – |
2020-01-23 |
4 |
D |
$68.00 |
$114,381,848 |
I/I |
(1,682,086) |
0 |
0 |
- |
|
| THOR |
Synthorx, Inc. |
Acting Chief Financial Officer |
• – – |
2018-12-11 |
4 |
B |
$11.00 |
$6,000,005 |
I/I |
545,455 |
1,682,086 |
1.99 |
- |
|
| JANX |
Janux Therapeutics, Inc. |
Acting Chief Financial Officer |
• – • |
2023-11-13 |
4 |
B |
$5.87 |
$4,988,643 |
I/I |
849,854 |
849,854 |
3.36 |
- |
|
| THOR |
Synthorx, Inc. |
Acting Chief Financial Officer |
• – – |
2018-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
1,136,631 |
1,136,631 |
0 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
